医学
肠道准备
胶囊内镜
胃肠病学
临床试验
疾病
内科学
内窥镜检查
外科
胶囊
梅德林
放射科
普通外科
克罗恩病
作者
Raphaëlle Rouveyre,Sandrine Coudol,Michael Collins,Astrid de Maissin,Mathurin Flamant,Caroline Trang,Marie Freyssinet,Guillaume Bouguen,Nina Dib,Arnaud Bourreille,Catherine Le Berre
摘要
BACKGROUND: Small bowel (SB) capsule endoscopy (SBCE) is a key tool in patients with Crohn's disease (CD). Optimal bowel preparation remains debated. AIMS: To compare the efficacy of a simplified preparation (clear liquid diet with 500 mL of water pre- and 1 L post-capsule ingestion) to a polyethylene glycol (PEG)-based preparation (24 h-residue-free diet with 2 L of PEG) in patients with established CD. METHODS: In this randomised, controlled, single-blind, superiority, multicentre trial, patients were assigned 1:1 to either the simplified preparation or the PEG-based preparation. Intestinal cleanliness (quantified by the KODA score and qualitatively evaluated), patient acceptability, diagnostic yield, capsule completion rate, and SB transit time (SBTT) were compared between groups. RESULTS: With 142 SBCE, we observed no difference in intestinal cleanliness. Patients' acceptability of preparation and SBCE procedure was significantly higher with the simplified preparation. Diagnostic yield was similar, as well as the capsule completion rate and SBTT. The area under the receiver operating characteristic curve of the KODA score was 0.87 (95% CI: 0.84-0.90). Using a threshold of 2.25, the score allowed us to discriminate images with 'good' and 'fair or poor' cleanliness with accuracy, sensitivity, and specificity of 80%, 76%, and 84%, respectively. CONCLUSIONS: A simplified preparation consisting of a clear liquid diet and water is a viable alternative to a PEG-based preparation prior to SBCE in patients with CD, offering comparable SB cleanliness and diagnostic outcomes while improving acceptability. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT05117996 and the article was written in line with the Consolidated Standards of Reporting Trials (CONSORT) checklist.
科研通智能强力驱动
Strongly Powered by AbleSci AI